OPKO Health
OPK
OPKO Health (OPK) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.01
- EPS estimate
- −$0.08
- EPS surprise
- +87.50%
- Revenue surprise
- +24.59%
- Revenue
- $163.5M
- Revenue estimate
- $131.2M
- Reported
- Jul 27, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 27, 2026 | −$0.08 | −$0.01 | +87.50% | $163.5M | SEC |
| Q1 2026 | Apr 28, 2026 | −$0.07 | −$0.07 | +0.00% | $124.2M | SEC |
| Q4 2025 | Feb 26, 2026 | −$0.07 | −$0.04 | +41.69% | $148.5M | SEC |
| Q3 2025 | Oct 29, 2025 | −$0.06 | $0.03 | +150.00% | $151.7M | SEC |
| Q2 2025 | Jul 31, 2025 | −$0.11 | −$0.19 | −67.70% | $156.8M | SEC |
| Q1 2025 | Apr 30, 2025 | −$0.07 | −$0.10 | −45.77% | $149.9M | SEC |
| Q4 2024 | Feb 27, 2025 | −$0.09 | $0.01 | +110.72% | $183.6M | SEC |
| Q3 2024 | Nov 7, 2024 | −$0.09 | $0.03 | +132.15% | $173.6M | SEC |
| Q2 2024 | Aug 7, 2024 | −$0.10 | −$0.01 | +89.47% | $182.2M | SEC |
| Q1 2024 | May 7, 2024 | −$0.10 | −$0.12 | −25.79% | $173.7M | SEC |
| Q4 2023 | Feb 27, 2024 | −$0.10 | −$0.09 | +10.00% | $181.9M | SEC |
| Q3 2023 | Nov 6, 2023 | −$0.10 | −$0.11 | −10.00% | $178.6M | SEC |
| Q2 2023 | Aug 3, 2023 | −$0.07 | −$0.03 | +58.16% | $265.4M | SEC |
| Q1 2023 | May 3, 2023 | −$0.08 | −$0.02 | +73.92% | $237.6M | SEC |
| Q4 2022 | Feb 23, 2023 | −$0.11 | −$0.11 | +1.52% | $185.4M | SEC |
| Q3 2022 | Nov 8, 2022 | −$0.08 | −$0.11 | −30.95% | $179.7M | SEC |
| Q2 2022 | Aug 4, 2022 | $0.01 | −$0.14 | −1850.00% | $309.9M | SEC |
| Q1 2022 | May 9, 2022 | −$0.06 | −$0.08 | −42.86% | $329.2M | SEC |
| Q4 2021 | Feb 24, 2022 | −$0.02 | −$0.11 | −450.00% | $401.3M | SEC |
| Q3 2021 | Oct 28, 2021 | −$0.01 | $0.04 | +500.00% | $385.8M | SEC |
Quarterly revenue
Frequently asked questions
When did OPKO Health (OPK) last report earnings?
OPKO Health last reported on Jul 27, 2026, covering fiscal Q2 2026.
Did OPK beat earnings estimates?
Yes. OPKO Health reported EPS of −$0.01 for Q2 2026 against a −$0.08 estimate — a 87.50% beat.
How much revenue did OPK report last quarter?
OPKO Health reported $163.5M in revenue for Q2 2026, against a consensus estimate of $131.2M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.